Cytoskeletal remodeling in vascular smooth muscle cells in response to angiotensin II-induced activation of the SHP-2 tyrosine phosphatase

被引:15
作者
Fernstrom, K [1 ]
Farmer, P [1 ]
Ali, MS [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
关键词
D O I
10.1002/jcp.20436
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Angiotensin II is an octapeptide that regulates diverse cellular responses including the actin cytoskeletal organization. In this study, stable cell lines overexpressing wild-type or catalytically inactive SHP-2 were employed to elucidate the signaling pathway utilized by the SHP-2 tyrosine phosphatase that mediates an angiotensin II-induced reorganization of the actin cytoskeleton in vascular smooth muscle cells (VSMC). The expression of wild-type SHP-2 prevented an angiotensin 11 dependent increase in stress fiber formation. In contrast, the catalytically inactive mutant SHP-2 increased stress fiber formation. Additional observations further established that SHP-2 regulates the reorganization of the actin cytoskeleton through RhoA- and Vav2-dependent signaling pathways. The expression of wild-type SHP-2 caused a dephosphorylation of several focal adhesion associated proteins including paxillin, p130Cas, and tensin in VSMC. This dephosphorylation of focal adhesion associated proteins was accompanied by significantly decreased numbers of focal adhesions within cells. These results demonstrate a unique role for SHP-2 in the regulation of the cellular architecture of VSMC, suggesting the possibility that this phosphatase might be instrumental in vascular remodeling.
引用
收藏
页码:402 / 413
页数:12
相关论文
共 41 条
[1]   Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation [J].
Aghazadeh, B ;
Lowry, WE ;
Huang, XY ;
Rosen, MK .
CELL, 2000, 102 (05) :625-633
[2]   Rho plays an important role in angiotensin II-induced hypertrophic responses in cardiac myocytes [J].
Aikawa, R ;
Komuro, I ;
Nagai, R ;
Yazaki, Y .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2000, 212 (1-2) :177-182
[3]   Jak2 acts as both a STAT1 kinase and as a molecular bridge linking STAT1 to the angiotensin II AT1 receptor [J].
Ali, MS ;
Sayeski, PP ;
Bernstein, KE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) :15586-15593
[4]   Angiotensin II stimulates tyrosine phosphorylation and activation of insulin receptor substrate 1 and protein-tyrosine phosphatase 1D in vascular smooth muscle cells [J].
Ali, MS ;
Schieffer, B ;
Delafontaine, P ;
Bernstein, KE ;
Ling, BN ;
Marrero, MB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (19) :12373-12379
[5]   Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT(1) receptor [J].
Ali, MS ;
Sayeski, PP ;
Dirksen, LB ;
Hayzer, DJ ;
Marrero, MB ;
Bernstein, KE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (37) :23382-23388
[6]   Angiotensin II activates RhoA in cardiac myocytes - A critical role of RhoA in angiotensin II-induced premyofibril formation [J].
Aoki, H ;
Izumo, S ;
Sadoshima, J .
CIRCULATION RESEARCH, 1998, 82 (06) :666-676
[7]   Inhibition of ERK attenuates force development by lowering myosin light chain phosphorylation [J].
D'Angelo, G ;
Adam, LP .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 282 (02) :H602-H610
[8]   Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells [J].
Doan, T ;
Farmer, P ;
Cooney, T ;
Ali, MS .
CELLULAR SIGNALLING, 2004, 16 (03) :301-311
[9]   SHP-2 is involved in heterodimer specific loss of phosphorylation of Tyr771 in the PDGF β-receptor [J].
Ekman, S ;
Kallin, A ;
Engström, U ;
Heldin, CH ;
Rönnstrand, L .
ONCOGENE, 2002, 21 (12) :1870-1875
[10]   The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/Mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells [J].
Frearson, JA ;
Alexander, DR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (09) :1417-1426